India's Broadband Boom Frames a Busy Week for Auto Earnings

A Billion-Subscriber Milestone

India's broadband network crossed 1.11 billion subscribers in September 2026, per TRAI data. That figure capped six consecutive months of growth in total broadband connections. Fixed wired broadband also extended its own six-month rising streak, reaching 35.1 million subscribers in the same month. The run is notable for its consistency: both series have moved in the same direction every month since March.

The clearest corporate read lands on MARUTI, which reports today. India vehicle registration data, tracked by ORTEX, leads Maruti Suzuki's revenue by 58 days. With three of three months of the current quarter now in, that dataset is running 31% above the same quarter a year ago. The fit is flagged as weak, so the signal carries uncertainty, but the direction is firm.

European Auto Registers Send Mixed Signals

Three European carmakers report this week, and the registration data pointing toward each of them tells different stories.

MBG (Mercedes-Benz Group) reports on 28 October. Dutch car registration data, which ORTEX measures as a strong-fit lead for Mercedes revenue by 26 days, is running 6% below the same quarter last year with all three months counted. Finnish registrations, a weaker-fit lead by 22 days, are running 36% above year-ago levels. The two signals pull in opposite directions.

VOW3 (Volkswagen) and RNO (Renault) both report on 29 October. Austrian car registrations, a moderate-fit lead for Volkswagen revenue by 18 days, are down 6% year-on-year with the full quarter in. For Renault, Austrian registrations run ahead by 32 days and show a 6% year-on-year gain. Renault's Dutch registrations, a 43-day moderate-fit lead, are down 19% on the same quarter last year. A000270 (Kia) follows on 30 October, with Austrian registrations up 9% year-on-year as a 45-day moderate-fit lead.

RACE (Ferrari) reports on 3 November. Austrian registrations, a 22-day weak-fit lead, are running 75% below the same quarter a year ago with three months in.

Retail Attention and Clinical Signals

Wikipedia page view data tracked by ORTEX showed a sharp spike in retail attention this week. Views for VTES (Vanguard's short-term tax-exempt bond ETF) and CGMM each ran 10.0 standard deviations above their own histories in the week to 21 October. Separately, ORTEX drug trial completion data for IMRX (Immuneering Corporation) showed trial completion date slippage running 1.8 standard deviations below its own history as of 9 October, indicating a faster-than-typical pace of trial progress.